Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Interactive online module to improve vaginal health education during pregnancy

Official title: Utilizing Electronic Modules to Educate on Sexual Health Practices During Pregnancy

Run by Loyola University · NCT07497971 · Data updated 2026-11-12

Pregnant individuals receiving routine prenatal care are randomly assigned to try an interactive educational module on sexual health and intimacy during pregnancy or to read a standard ACOG article, to see if the module improves knowledge and comfort discussing sexual health with providers.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorLoyola University
Academic / other
Locations1 site (Maywood, Illinois)
StatusRecruiting
StartedFebruary 28, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedAugust 26, 2026
Trial IDNCT07497971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with low-risk pregnancies at or beyond 12 weeks, English-speaking, receiving routine prenatal care, not currently under maternal-fetal medicine for high-risk conditions.

Probably not a fit

Pregnant individuals with high-risk pregnancies or those requiring pelvic rest or who are advised to abstain from intercourse may not benefit from this specific education module.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study compares an interactive, evidence-based online education module about sexual health and intimacy during pregnancy with a standard ACOG article. Participants are adults 18+ with low-risk pregnancies at 12 weeks or more, English-speaking, and receiving routine prenatal care at Loyola University Medical Center. Outcomes include changes in knowledge, comfort discussing sexual concerns, and sexual function, measured before, immediately after, and two weeks later. The goal is to determine whether an engaging digital education tool can enhance patient knowledge and communication in prenatal care. The study is prospective and randomized with a 1:1 assignment to intervention or control.

Why it matters

Potential benefit: If successful, the educational module could help more pregnant patients understand safe sexual activity and feel comfortable discussing sexual health with their clinicians.

How similar studies have gone: Previous digital education efforts in pregnancy have shown improvements in knowledge and communication in some settings, but this exact interactive module is a novel approach in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant individuals at or beyond 12 weeks gestation
* Age 18 years or older
* English speaking with English reading proficiency
* Experiencing a low risk pregnancy with no major complications
* Not currently followed by Maternal-Fetal Medicine (MFM) for high risk pregnancy management

Exclusion Criteria:

* Pregnancy complications requiring management by Maternal-Fetal Medicine (MFM)
* Placed on pelvic rest
* Advised by their provider to abstain from sexual intercourse

Where it's running

  • Loyola University Medical Center
    Maywood, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Mary Lynn, DO — Loyola University Chicago
  • Study coordinator: Mary Lynn, DO
  • Email: MLYNN@lumc.edu
  • Phone: 708-327-1450

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.